# Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™

> **NCT01084408** · PHASE3 · TERMINATED · sponsor: **University Hospital, Saarland** · enrollment: 90 (estimated)

## Conditions studied

- Coronary De-novo Stenoses

## Interventions

- **DEVICE:** SeQuent®Please (Paclitaxel coated balloon)
- **DEVICE:** Taxus™Liberté™ (Paclitaxel eluting stent)

## Key facts

- **NCT ID:** NCT01084408
- **Lead sponsor:** University Hospital, Saarland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03-01
- **Primary completion:** 2012-03-01
- **Final completion:** 2013-03-01
- **Target enrollment:** 90 (ESTIMATED)
- **Why stopped:** no suitable patients
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084408, "Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01084408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*